Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization-March 2024-www.financetom.com

Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Candel Therapeutics Partners With IDEA Pharma for CAN-2409 Commercialization

Mar 20, 2025 5:55 AM

08:28 AM EDT, 03/20/2025 (MT Newswires) -- Candel Therapeutics ( CADL ) and IDEA Pharma said Thursday they have entered a commercial partnership to support the development and potential market launch of Candel's lead candidate CAN-2409.

As part of the agreement, set to continue through next year, IDEA will provide strategic guidance as Candel prepares a biologics license application for CAN-2409 in prostate cancer, the companies said.

The partnership follows encouraging late-stage results showing the treatment improved disease-free survival and reduced recurrence, the companies said.

Previous page： Amerigo Q2 revenue misses estimates Next page： AEP beats profit estimates, expects new five-year capital plan of $70 billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amerigo Q2 revenue misses estimates

Jul 30, 2025

Overview * Amerigo Q2-2025 revenue misses analyst expectations, net income $7.5 mln * Company returned $7.6 mln to shareholders via dividends and buybacks * Amerigo's EBITDA for Q2-2025 was $17.8 mln Outlook * Amerigo aims to be debt-free by year-end 2025 * Company expects strong long-term global copper demand * Amerigo anticipates upward pressure on copper prices * Company on...

AEP beats profit estimates, expects new five-year capital plan of $70 billion

Jul 30, 2025

July 30 (Reuters) - American Electric Power ( AEP ) beat Wall Street estimates for second-quarter profit on Wednesday, and said it expects to announce a new, five-year capital plan this fall of about $70 billion to meet growing energy needs in the U.S. Shares were up 1% at $110.34 in premarket trading. In April, the U.S. Energy Information Administration...

Ionis Pharmaceuticals Swings to Q2 Profit, Revenue Increases

Jul 30, 2025

07:45 AM EDT, 07/30/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported Q2 earnings Wednesday of $0.70 per diluted share, swinging from a loss of $0.45 a year earlier. Analysts polled by FactSet expected a loss of $0.09. Revenue for the quarter ended June 30 was $452 million, compared with $225 million a year earlier. Analysts surveyed by FactSet...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...